CCL18 and glioblastoma: A total of 10 genes were identified as potential oncogenic regulators in recurrent GBM, including CCL18, CCL8, FCGR2B, GABRD, PRAME, SCN1B, SNCB, SYN1, TUBA4A, and VSNL1 (Figure 2A).